QQQ   385.05 (-0.58%)
AAPL   192.32 (-0.57%)
MSFT   368.80 (-1.00%)
META   317.45 (-0.26%)
GOOGL   130.02 (-0.74%)
AMZN   144.52 (-1.61%)
TSLA   239.37 (+0.27%)
NVDA   455.03 (-2.28%)
NIO   7.76 (+4.44%)
BABA   71.51 (-1.20%)
AMD   116.82 (-1.32%)
T   16.95 (-1.57%)
F   10.70 (+0.94%)
MU   73.13 (-0.76%)
CGC   0.70 (+4.49%)
GE   119.82 (-0.34%)
DIS   91.51 (+0.79%)
AMC   6.79 (-3.28%)
PFE   28.81 (-1.00%)
PYPL   59.53 (+2.78%)
XOM   99.11 (-1.32%)
QQQ   385.05 (-0.58%)
AAPL   192.32 (-0.57%)
MSFT   368.80 (-1.00%)
META   317.45 (-0.26%)
GOOGL   130.02 (-0.74%)
AMZN   144.52 (-1.61%)
TSLA   239.37 (+0.27%)
NVDA   455.03 (-2.28%)
NIO   7.76 (+4.44%)
BABA   71.51 (-1.20%)
AMD   116.82 (-1.32%)
T   16.95 (-1.57%)
F   10.70 (+0.94%)
MU   73.13 (-0.76%)
CGC   0.70 (+4.49%)
GE   119.82 (-0.34%)
DIS   91.51 (+0.79%)
AMC   6.79 (-3.28%)
PFE   28.81 (-1.00%)
PYPL   59.53 (+2.78%)
XOM   99.11 (-1.32%)
QQQ   385.05 (-0.58%)
AAPL   192.32 (-0.57%)
MSFT   368.80 (-1.00%)
META   317.45 (-0.26%)
GOOGL   130.02 (-0.74%)
AMZN   144.52 (-1.61%)
TSLA   239.37 (+0.27%)
NVDA   455.03 (-2.28%)
NIO   7.76 (+4.44%)
BABA   71.51 (-1.20%)
AMD   116.82 (-1.32%)
T   16.95 (-1.57%)
F   10.70 (+0.94%)
MU   73.13 (-0.76%)
CGC   0.70 (+4.49%)
GE   119.82 (-0.34%)
DIS   91.51 (+0.79%)
AMC   6.79 (-3.28%)
PFE   28.81 (-1.00%)
PYPL   59.53 (+2.78%)
XOM   99.11 (-1.32%)
QQQ   385.05 (-0.58%)
AAPL   192.32 (-0.57%)
MSFT   368.80 (-1.00%)
META   317.45 (-0.26%)
GOOGL   130.02 (-0.74%)
AMZN   144.52 (-1.61%)
TSLA   239.37 (+0.27%)
NVDA   455.03 (-2.28%)
NIO   7.76 (+4.44%)
BABA   71.51 (-1.20%)
AMD   116.82 (-1.32%)
T   16.95 (-1.57%)
F   10.70 (+0.94%)
MU   73.13 (-0.76%)
CGC   0.70 (+4.49%)
GE   119.82 (-0.34%)
DIS   91.51 (+0.79%)
AMC   6.79 (-3.28%)
PFE   28.81 (-1.00%)
PYPL   59.53 (+2.78%)
XOM   99.11 (-1.32%)

Quanterix Stock Price, News & Analysis (NASDAQ:QTRX)

$23.20
-0.40 (-1.69%)
(As of 12/6/2023 ET)
Compare
Today's Range
$22.98
$24.13
50-Day Range
$19.54
$27.96
52-Week Range
$10.02
$28.77
Volume
370,426 shs
Average Volume
351,092 shs
Market Capitalization
$877.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$32.00

Quanterix MarketRank™ Stock Analysis

Analyst Rating
Buy
3.20 Rating Score
Upside/​Downside
37.9% Upside
$32.00 Price Target
Short Interest
Healthy
3.12% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
$501,970 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.78) to ($0.69) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.49 out of 5 stars

Medical Sector

125th out of 955 stocks

Analytical Instruments Industry

6th out of 25 stocks


QTRX stock logo

About Quanterix Stock (NASDAQ:QTRX)

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

QTRX Stock Price History

QTRX Stock News Headlines

Energy Storage Trend Ignites Frenzy Over Vanadium Supply
As the world shifts to renewables such as wind and solar, how will we store all this energy? Vanadium batteries are the breakthrough that some experts predict will be the future of grid-scale energy storage. The problem is, only 5% of vanadium is mined in the U.S. - and China and Russia have a stranglehold on our supply.
Energy Storage Trend Ignites Frenzy Over Vanadium Supply
As the world shifts to renewables such as wind and solar, how will we store all this energy? Vanadium batteries are the breakthrough that some experts predict will be the future of grid-scale energy storage. The problem is, only 5% of vanadium is mined in the U.S. - and China and Russia have a stranglehold on our supply.
Quanterix Releases Operating Results for Third Quarter 2023
Quanterix Corporation: Going For Three In A Row
A Preview Of Quanterix's Earnings
Analyst Expectations for Quanterix's Future
See More Headlines
Receive QTRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Quanterix and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/06/2023
Today
12/06/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
3/04/2024

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:QTRX
Fax
N/A
Employees
370
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$32.00
High Stock Price Target
$34.00
Low Stock Price Target
$30.00
Potential Upside/Downside
+37.9%
Consensus Rating
Buy
Rating Score (0-4)
3.20
Research Coverage
5 Analysts

Profitability

Net Income
$-96,700,000.00
Pretax Margin
-32.47%

Debt

Sales & Book Value

Annual Sales
$105.52 million
Book Value
$9.69 per share

Miscellaneous

Free Float
34,728,000
Market Cap
$877.66 million
Optionable
Not Optionable
Beta
1.27
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. Masoud Toloue Ph.D. (Age 42)
    President, CEO & Director
    Comp: $957.03k
  • Dr. David R. Walt Ph.D. (Age 70)
    Co-Founder, Chairman of Scientific Advisory Board & Independent Director
    Comp: $47.25k
  • Dr. Mark T. Roskey Ph.D. (Age 63)
    Senior Vice President of Strategic Partnerships
    Comp: $495.03k
  • Mr. Michael A. Doyle (Age 67)
    Executive Director of Finance
    Comp: $570.14k
  • Ms. Vandana Sriram CPA (Age 49)
    Chief Financial Officer
  • Mr. Daniel Pikora (Age 47)
    Chief Operating Officer
  • Dr. David C. Duffy Ph.D. (Age 52)
    Senior VP of Research & Development and CTO
    Comp: $299.05k
  • Ms. Alexandra Phillips
    Senior VP & Chief Information Officer
  • Ms. Laurie A. Churchill (Age 52)
    Senior VP, General Counsel & Secretary
  • David Panzerella
    Vice President of Sales














QTRX Stock Analysis - Frequently Asked Questions

Should I buy or sell Quanterix stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Quanterix in the last twelve months. There are currently 4 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" QTRX shares.
View QTRX analyst ratings
or view top-rated stocks.

What is Quanterix's stock price target for 2024?

5 brokers have issued 1-year price objectives for Quanterix's stock. Their QTRX share price targets range from $30.00 to $34.00. On average, they anticipate the company's share price to reach $32.00 in the next twelve months. This suggests a possible upside of 37.9% from the stock's current price.
View analysts price targets for QTRX
or view top-rated stocks among Wall Street analysts.

How have QTRX shares performed in 2023?

Quanterix's stock was trading at $13.85 on January 1st, 2023. Since then, QTRX shares have increased by 67.5% and is now trading at $23.20.
View the best growth stocks for 2023 here
.

When is Quanterix's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, March 4th 2024.
View our QTRX earnings forecast
.

How were Quanterix's earnings last quarter?

Quanterix Co. (NASDAQ:QTRX) announced its earnings results on Monday, November, 6th. The company reported ($0.21) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.35) by $0.14. The company earned $31.33 million during the quarter, compared to analysts' expectations of $27.79 million. Quanterix had a negative trailing twelve-month return on equity of 10.81% and a negative net margin of 33.03%.

What ETFs hold Quanterix's stock?

ETFs with the largest weight of Quanterix (NASDAQ:QTRX) stock in their portfolio include Simplify Health Care ETF (PINK) and Invesco Dorsey Wright Healthcare Momentum ETF (PTH).Invesco Nasdaq Future Gen 200 ETF (QQQS).

What guidance has Quanterix issued on next quarter's earnings?

Quanterix issued an update on its FY 2023 earnings guidance on Monday, November, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $118.00 million-$120.00 million, compared to the consensus revenue estimate of $115.21 million.

What is Kevin Hrusovsky's approval rating as Quanterix's CEO?

15 employees have rated Quanterix Chief Executive Officer Kevin Hrusovsky on Glassdoor.com. Kevin Hrusovsky has an approval rating of 70% among the company's employees.

What other stocks do shareholders of Quanterix own?
When did Quanterix IPO?

(QTRX) raised $50 million in an initial public offering (IPO) on Thursday, December 7th 2017. The company issued 3,300,000 shares at a price of $14.00-$16.00 per share. J.P. Morga and Leerink Partners served as the underwriters for the IPO and BTIG and Evercore ISI were co-managers.

Who are Quanterix's major shareholders?

Quanterix's stock is owned by a variety of institutional and retail investors. Top institutional investors include Invesco Ltd. (2.92%), Lord Abbett & CO. LLC (2.70%), FMR LLC (2.21%), Ashford Capital Management Inc. (2.11%), Platinum Investment Management Ltd. (1.76%) and Ameriprise Financial Inc. (1.68%). Insiders that own company stock include Amol Chaubal, David C Duffy, David C Duffy, David R Walt, Dawn Mattoon, E Kevin Hrusovsky, John J Fry, John J Fry, Marijn E Dekkers, Marijn E Dekkers, Mark T Roskey, Mark T Roskey, Masoud Toloue, Michael A Doyle and William P Donnelly.
View institutional ownership trends
.

How do I buy shares of Quanterix?

Shares of QTRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:QTRX) was last updated on 12/6/2023 by MarketBeat.com Staff

My Account -